IP Verse

Purification Process For Monoclonal Antibodies - EP3013849

The patent EP3013849 was granted to Cadila Healthcare on Sep 13, 2017. The application was originally filed on Jun 25, 2014 under application number EP14777867A. The patent is currently recorded with a legal status of "Revoked".

EP3013849

CADILA HEALTHCARE
Application Number
EP14777867A
Filing Date
Jun 25, 2014
Status
Revoked
Jan 22, 2024
Grant Date
Sep 13, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NEUEFEINDJun 13, 2018MAIWALDADMISSIBLE
WEINZIERLJun 13, 2018SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
CYTIVA SWEDENJun 12, 2018DEMOULINADMISSIBLE
F HOFFMANN LA ROCHEJun 12, 2018BOULT WADE TENNANTADMISSIBLE
AWA SWEDENMay 29, 2018AWA SWEDENADMISSIBLE

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1075488
DESCRIPTIONEP1308455
DESCRIPTIONEP1308456
DESCRIPTIONUS6417335
DESCRIPTIONUS6489447
DESCRIPTIONUS7863426
INTERNATIONAL-SEARCH-REPORTWO2013066707
OPPOSITIONEP1614693
OPPOSITIONUS2010069617
OPPOSITIONUS2010135987
OPPOSITIONUS2011097340
OPPOSITIONUS2012264920
OPPOSITIONUS2013260419
OPPOSITIONUS5429746
OPPOSITIONUS5641870
OPPOSITIONUS7385040
OPPOSITIONWO2005000898
OPPOSITIONWO2006099308
OPPOSITIONWO2006138553
OPPOSITIONWO2007109163
OPPOSITIONWO2008031020
OPPOSITIONWO2010030222
OPPOSITIONWO2010141039
OPPOSITIONWO2011050071
OPPOSITIONWO2011089212
OPPOSITIONWO2012051147
OPPOSITIONWO2012125735
OPPOSITIONWO2013066707
OPPOSITIONWO2013075849
OPPOSITIONWO2014207763
OPPOSITIONWO2014209508
OPPOSITIONWO9522389

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- CHEN ET AL, "Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, (20071226), vol. 1177, no. 2, doi:10.1016/J.CHROMA.2007.07.083, ISSN 0021-9673, pages 272 - 281, XP022401695 [X] 1-3,10-22,27-31 * paragraphs [02.1] , [ 3.1] , [3.4.2] * [I] 4-9,23-26,32-34
OPPOSITION- "chapter 1 principles of hydrophobic interaction chromatography", GE Healthcare HIC Handbook, 00002006, pages 1 - 23, XP055512620-
OPPOSITION- "chromotography columns and media", GE Healthcare Life Sciences catalogue, (20060000), pages 612 - 621, XP055512867-
OPPOSITION- "chromotography columns and media ion exchange", GE Healthcare Life Sciences catalogue, (20060000), pages 592 - 608, XP055512876-
OPPOSITION- curling j., "THE DEVELOPMENT OF ANTIBODY PURIFICATION TECHNOLOGIES", Process Scale Purification of Antibodies, Hobo- ken, (20090000), pages 25 - 52, XP055512946-
OPPOSITION- GE Healthcare Life Sciences, "Hydrophobic Interaction Chromatography (HIC) Selection Guide", Hydrophobic Interaction Chromatography (HIC) Selection Guide, (20120600), pages 1 - 12, XP055512628-
OPPOSITION- "Hydrophobic Interaction Chromatography", Tosoh Bioscience separation business unit, pages 1 - 12-
OPPOSITION- "Media characteristics", GE Healthcare Affinity Chromatography Principles and Methods, (20070000), pages 33 - 37, XP055512625-
OPPOSITION- "Procedure 29-0081-28 AA MAb capture step development using Mabselect sure", GE Healthcare Life Sciences, (20111200), pages 1 - 4, XP055512821-
OPPOSITION- Sanchayita Chose,, "Protein A Affinity Chromatography for Capture and Purification of Monoclonal Antibodies and Fe-Fusion Proteins: Practical Considerations for Process Development", Process Scale Bioseparations for the Biopharmaceutical Industry, 00002007, pages 463 - 489, XP055512962-
OPPOSITION- SHUKLA et al., "Downstream processing of monoclonal antibodies-Application of platform approaches", Journal of Chromatography B, (20070000), vol. 848, pages 29 - 39, XP055493686-
OPPOSITION- "Strategies for Protein Purification handbook", GE Healthcare, (20100000), pages 25 - 26, XP055476779-
OPPOSITION- S VUNNUM et al., "PROTEIN A-BASED AFFINITY CHROMATOGRAPHY", Process Scale Purification of Antibodies, Hoboken, (20090000), pages 79 - 102, XP055512935-
OPPOSITION- CHEN et al., "Comparison of standard and new generation Available online 7 hydrophobic interaction chromatography resins in the August 2007 monoclonal antibody purification process", Journal of Chromatography, (20080000), vol. 117, pages 272 - 281, XP022401695
OPPOSITION- CHEN et al., "Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process", Journal of Chromatography A, (20080000), vol. 1177, pages 272 - 281, XP022401695
OPPOSITION- SHUKLA et al., Journal of Chromatography, (20070000), vol. 848, pages 28 - 39, XP005922825
OPPOSITION- H GRUNFELD et al., "Reduction of bovine immunoglobulin contamination from monoclonal antibodies by SOURCE<TM> 15PHE chromatography", J Immunol Meth, (19970000), vol. 201, pages 233 - 241, XP004053994
OPPOSITION- FAHRNER et al., "INDUSTRIAL PURIFICATION OF PHARMACEUTICAL ANTIBODIES: DEVELOPMENT, OPERATION, AND VALIDATION OF CHROMATOGRAPHY PROCESSEs", Biotechnology and Genetic Engineering Reviews, (20010000), vol. 18, pages 301 - 327, XP008034714
OPPOSITION- LIU et al., "Recovery and purification process development for monoclonal antibody production", Landes Bioscience, (20100000), vol. 2, no. 5, pages 480 - 499, XP002691388
OPPOSITION- LIU et al., "Recovery and purification process development for monoclonal antibody production", mAbs, (20100000), vol. 2, no. 5, pages 480 - 499, XP002691388

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents